The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ABBVIE INC COM 00287Y109 3,750 35,000 SH   SOLE   35,000 0 0
ADAMAS PHARMACEUTICALS INC COM 00548A106 433 100,000 SH   SOLE   100,000 0 0
AMARIN CORP PLC SPONS ADR NEW 023111206 1,467 300,000 SH Call SOLE   300,000 0 0
ANTARES PHARMA INC COM 036642106 1,995 500,000 SH   SOLE   500,000 0 0
CARDINAL HEALTH INC COM 14149Y108 1,339 25,000 SH   SOLE   25,000 0 0
CLOVIS ONCOLOGY INC COM 189464100 1,200 250,000 SH   SOLE   250,000 0 0
GAMIDA CELL LTD SHS M47364100 420 50,000 SH   SOLE   50,000 0 0
GILEAD SCIENCES INC COM 375558103 2,913 50,000 SH   SOLE   50,000 0 0
GLAXOSMITHKLINE PLC SPONSORED ADR 37733W105 3,680 100,000 SH   SOLE   100,000 0 0
GREENLANE HLDGS INC CL A 395330103 990 250,000 SH   SOLE   250,000 0 0
JAZZ PHARMACEUTICALS PLC SHS USD G50871105 1,651 10,000 SH   SOLE   10,000 0 0
MCKESSON CORP COM 58155Q103 1,739 10,000 SH   SOLE   10,000 0 0
MODERNA INC COM 60770K107 1,045 10,000 SH Put SOLE   10,000 0 0
NOVAVAX INC COM NEW 670002401 558 5,000 SH Put SOLE   5,000 0 0
PROSHARES TR II VIX SH TRM FUTRS 74347W171 687 50,000 SH Call SOLE   50,000 0 0
TYME TECHNOLOGIES INC COM 90238J103 2,654 2,175,000 SH   SOLE   2,175,000 0 0
VYNE THERAPEUTICS INC COM NEW 92941V100 3,160 2,000,000 SH   SOLE   2,000,000 0 0